← Back to Search

Other

Blood Flow Restriction for Clinical Trials

N/A
Waitlist Available
Research Sponsored by University of Central Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 3, week 4 and 8, day 29
Awards & highlights

Study Summary

This trial will compare the benefits of two different types of strength training for people with Multiple Sclerosis.

Eligible Conditions
  • Clinical Trials
  • Blood Flow Restriction
  • Multiple Sclerosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 3, week 4 and 8, day 29
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 3, week 4 and 8, day 29 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Functional Outcomes- 10meter
Change in Functional Outcomes- 30CST
Change in Functional Outcomes- 6min walk
+2 more
Secondary outcome measures
Changes in Strength

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Blood Flow RestrictionExperimental Treatment1 Intervention
The BFR group will complete 1 set of 30 (1 x 30) at 30% of their 1 repetition maximum for leg press, leg extension, leg curl, chest press, seated row, and shoulder press completed on exercise machines with 2 minutes between exercises.
Group II: Standard of CareActive Control1 Intervention
The standard of care group will complete 1 set of 8-12 repetitions at 60-80% of their 1 repetition maximum for leg press, leg extension, leg curl, chest press, seated row, and shoulder press completed on exercise machines with 2 minutes between exercises.

Find a Location

Who is running the clinical trial?

University of Central FloridaLead Sponsor
79 Previous Clinical Trials
1,098,346 Total Patients Enrolled
AdventHealthOTHER
107 Previous Clinical Trials
29,549 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities available to participate in this research project?

"That is correct. The information available on clinicaltrials.gov reveals that this trial is currently seeking participants. This study was first posted on January 1st, 2022 and was last updated on December 15th, 2021. They are looking for 30 individuals from 1 location."

Answered by AI

Is this research project limited to a certain age demographic?

"The age limit for participants in this study is 55 years old. All participants must also be older than 18 years old."

Answered by AI

Would I be able to join this research project if I qualify?

"Eligible participants for this study must be between 18-55 years old, have a current diagnosis of multiple sclerosis, a female sex, an Expanded Disability Status Score of 6.5 or lower, the ability to walk unassisted for 10 meters, and the commitment to attend all 29 testing sessions over the 14 weeks that the trial will take place."

Answered by AI

Who else is applying?

What state do they live in?
Florida
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis
2022. "Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05177952.
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top